About AmplifyBio
AmplifyBio is a Healthcare company based in Hilliard (United States) founded in 2021. It provides contract research, development, and manufacturing services for biologic drugs. It operates on a B2B model. AmplifyBio has raised $229.75 million across 3 funding rounds. Its focus areas include Biotechnology, Drug Development and Contract Manufacturing. Its competitors include Catalent, Surrozen and Curia; 1 of its 3 listed competitors has raised funding.
Company details
AmplifyBio provides contract research, development, and manufacturing services for biologic drugs through providing healthcare solutions, advancing biotech innovations, drug development, and contract manufacturing. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Hilliard, United States
- SectorsHealthcare
- Website amplify-bio.com
- Social X
- Total Equity Funding$229.75M (USD)
in 3 rounds
- Latest Funding Round$49.75M (USD), Series C
Oct 2023
Funding Insights of AmplifyBio
AmplifyBio has successfully raised a total of $229.75M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $49.75 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $229.75M
- Total Rounds 3
- Last Round Series C — $49.75M
- First Round $80M
(May 2021)
All 4 funding rounds of AmplifyBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | $49.75M | Series C | – | – | – |
| Jan 2023 | Debt – Conventional | – | – | ||
| Apr 2022 | $100M | Series C | – | – | – |
| May 2021 | $80M | Series C | – | – | – |
People of AmplifyBio
19 people are tracked at AmplifyBio (10 in leadership, 4 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Jerry Hacker | EVP & Chief Commercial Officer | Leadership |
Mark Perry | Director of Business Development | Leadership |
J. Kelly Ganjei | President & CEO | Leadership |
Dean Kobs | Vice President Of CRO Operations | Leadership |
Andrew Conroy | Associate Director Research And Development | Leadership |
Greg Kastner | Director of Operations | Leadership |
Christine Commons | Director Of Vivarium Operations | Leadership |
Christopher Elders | Study Director | Leadership |
Amanda H. | Director Of Biosafety Operations | Leadership |
Josh Merkel | Director of Manufacturing Sciences & Technology | Leadership |
Matt Vaughan | Director | Board & advisors |
Rohan Nirody | Director | Board & advisors |
Shaun Rodriguez | Director | Board & advisors |
Lewis Von Thaer | Director | Board & advisors |
Hercules Hurtado | Warehouse Supervisor | Team |
Prasannakumar Kanderi | Senior Enterprise Systems Engineer | Team |
Allison Cheung | Senior Manager, Bioanalytics QC | Team |
Hubert Frédéric Arokium | Senior Scientist | Team |
Felix Marusic | Principal Application And Systems Analyst | Team |
Complete people profiles for AmplifyBio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AmplifyBio
3 dated milestones of AmplifyBio across 2 years, from founding to its latest funding, stage changes and deals.
- Founded AmplifyBio is founded.
- Funding First funding round of $80.0M.
- Funding Latest funding round, Series C, of $49.8M.
Competitors of AmplifyBio
AmplifyBio has 3 listed competitors in our database, 1 of them funded. They include Catalent, Surrozen and Curia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| catalent.com | 2007 | Somerset, United States | 9,390 | CDMO offering drug and biologics development services | ||
| surrozen.com | 2016 | San Francisco, United States | $133M | 80 | Selective Wnt agonists are developed for human tissue regeneration. | |
| curiaglobal.com | 1991 | Albany, United States | 1,918 | Drug research, development, testing, and consulting services are provided. |
Detailed competitors of AmplifyBio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as AmplifyBio (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Amplifybio
Complete news archive for AmplifyBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AmplifyBio
AmplifyBio was founded in 2021.
AmplifyBio is headquartered in Hilliard, United States. It is registered at Hilliard, Ohio, United States.
AmplifyBio is a funded company, having raised a total of $229.75M across 3 funding rounds to date. The company's 1st funding round was a Series C of $80M, raised on May 2021.
AmplifyBio provides contract research, development, and manufacturing services for biologic drugs through providing healthcare solutions, advancing biotech innovations, drug development, and contract manufacturing. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.